Details of the Drug

General Information of Drug (ID: DMN1RMO)

Drug Name
Stanozolol
Synonyms
stanozolol; Androstanazole; Winstrol; Androstanazol; 10418-03-8; Stromba; Stanazolol; Winstrol Depot; Strombaject; Tevabolin; Estazol; Winstroid; Anabol; Winstrol V; Estanozolol; Stanozololum; Stanozolo [DCIT]; Androstanazole (VAN); WIN 14833; Stanozolol (1'H form); Winstrol-V; Stanozololum [INN-Latin]; Estanozolol [INN-Spanish]; UNII-4R1VB9P8V3; Androstanazolestanazol; HSDB 3185; Stanozolol (2'H form); EINECS 233-894-8; NSC 43193; NSC 233046; 4R1VB9P8V3; CHEBI:9249; 2'H-Androst-2-eno(3,2-c)pyrazol-17-ol, 17-methyl-, (5alpha,17beta)-
Indication
Disease Entry ICD 11 Status REF
Hereditary angioedema 4A00.14 Approved [1]
Affected Organisms
Humans and other mammals
ATC Code
A14AA02: Stanozolol
A14AA: Androstan derivatives
A14A: ANABOLIC STEROIDS
A14: ANABOLIC AGENTS FOR SYSTEMIC USE
A: ALIMENTARY TRACT AND METABOLISM
A14AA02: Stanozolol
A14AA: Androstan derivatives
A14A: ANABOLIC STEROIDS
A14: ANABOLIC AGENTS FOR SYSTEMIC USE
A: ALIMENTARY TRACT AND METABOLISM
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C21H32N2O
Canonical SMILES
CC12CCC3C(C1CCC2(C)O)CCC4C3(CC5=C(C4)NN=C5)C
InChI
InChI=1S/C21H32N2O/c1-19-11-13-12-22-23-18(13)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,24H,4-11H2,1-3H3,(H,22,23)/t14-,15+,16-,17-,19-,20-,21-/m0/s1
InChIKey
LKAJKIOFIWVMDJ-IYRCEVNGSA-N
Cross-matching ID
PubChem CID
25249
ChEBI ID
CHEMBL9249
CAS Number
302-96-5
UNII
4R1VB9P8V3
DrugBank ID
DB06718
TTD ID
D08QKJ
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug Pharmacogenomic Perturbation (DPP)NEW Click to Jump to the Detailed DPP Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015